OpenVSafe by OpenVAERS
Search V-safe

QZC-23823-69471

3 vaccinations 1 coded response 6 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
16-20
ZIP prefix
329 / FL
Registered
2022-01-14
Relationship
Adult relative or friend
Guardian
9L8-12010-90852
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-05
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-26
    Dose 2 — Pfizer-BioNTech
  3. 2022-01-11
    Dose 3 — Moderna
  4. 2022-01-14
    Registered in v-safe
  5. 2022-01-14
    Survey response — days 1–6 daily, dose 3, dependent
    MedDRA: Dizziness — Feeling: Poor · Fever · Chills, Fatigue or tiredness, Nausea, Vomiting, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: dizzy
    MedDRA releases: 2024-11 · check-in free text available
  6. 2022-01-15
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  7. 2022-01-16
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  8. 2022-01-17
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  9. 2022-01-25
    Health check-in — day 14, dose 3, dependent
    Feeling: Good
    Adult check-in
  10. 2022-07-14

Vaccinations

DoseDateManufacturerCo-administered
12021-03-05Pfizer-BioNTech No
22021-03-26Pfizer-BioNTech No
32022-01-11Moderna No

Free text

Release 10 — days 1–6 daily, dose 3, dependent

2022-01-14

Systemic reaction (other): dizzy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SRODizziness · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release